기사 본문 영역

상세페이지

CLINICAL TRIAL OF TREATMENT USING BLOOD PLASMA
입력 2020.07.13 (15:56) 수정 2020.07.13 (16:46) News Today
자동재생
동영상영역 시작
CLINICAL TRIAL OF TREATMENT USING BLOOD PLASMA
동영상영역 끝
[Anchor Lead]

Clinical trials are underway on some 900 COVID-19 treatments across the globe but no clear prospects regarding their availability and effectiveness are being shown. On the home front, a clinical trial will soon begin to test a treatment using blood plasma.

[Pkg]

This community health center worker in Bundang, Gyeonggi-do Province, was confirmed to be infected with COVID-19 back in late March. Sohn Bok-sim fully recovered after receiving medical treatment for 40 days. She now wants to do something to help the fight against the virus. So Sohn decided to donate her blood plasma, which is needed for the development of a COVID-19 cure.

[Soundbite] "It'll sting a bit. Don't move. Here it goes."

People who have completely recovered from the disease carry antibodies in their blood plasma that can attack and defeat the virus. Therefore, their blood plasma is the most crucial element in developing a cure.

[Soundbite] SOHN BOK-SIM(FORMER COVID-19 PATIENT) : "While receiving no particular treatment, I was just waiting to hear that I tested negative for the virus. I desperately wished that a cure would be developed quickly."

About 170 recovered patients donated their blood plasma. Sufficient amount for clinical trial has been collected. But there's still a long way to go. Donation applicants must be confirmed to be fit in the first selective test. Next, they will donate their blood in hospitals. Across the nation, only four hospitals can receive blood plasma donations. Three of them are located in Daegu and Gyeongsangbuk-do Province. Even if there are applicants, the process is complicated. But medical experts stress now is the best time to develop a blood plasma-based COVID-19 cure. The level of neutralizing antibodies in blood plasma begins to decrease three or four months after infections.

[Soundbite] CHOI WON-SEOK(PROF. KOREA UNIVERSITY ANSAN HOSPITAL) : "The level of antibodies drops naturally. We need more blood donations so that there's enough to conduct three rounds of clinical trials and develop the cure."

Health authorities appropriated an extra budget of 45 billion won to support the development of a COVID-19 treatment. They will also come up with measures to encourage blood plasma donations, such as deploying blood collection buses in hospitals.
  • CLINICAL TRIAL OF TREATMENT USING BLOOD PLASMA
    • 입력 2020.07.13 (15:56)
    • 수정 2020.07.13 (16:46)
    News Today
CLINICAL TRIAL OF TREATMENT USING BLOOD PLASMA
[Anchor Lead]

Clinical trials are underway on some 900 COVID-19 treatments across the globe but no clear prospects regarding their availability and effectiveness are being shown. On the home front, a clinical trial will soon begin to test a treatment using blood plasma.

[Pkg]

This community health center worker in Bundang, Gyeonggi-do Province, was confirmed to be infected with COVID-19 back in late March. Sohn Bok-sim fully recovered after receiving medical treatment for 40 days. She now wants to do something to help the fight against the virus. So Sohn decided to donate her blood plasma, which is needed for the development of a COVID-19 cure.

[Soundbite] "It'll sting a bit. Don't move. Here it goes."

People who have completely recovered from the disease carry antibodies in their blood plasma that can attack and defeat the virus. Therefore, their blood plasma is the most crucial element in developing a cure.

[Soundbite] SOHN BOK-SIM(FORMER COVID-19 PATIENT) : "While receiving no particular treatment, I was just waiting to hear that I tested negative for the virus. I desperately wished that a cure would be developed quickly."

About 170 recovered patients donated their blood plasma. Sufficient amount for clinical trial has been collected. But there's still a long way to go. Donation applicants must be confirmed to be fit in the first selective test. Next, they will donate their blood in hospitals. Across the nation, only four hospitals can receive blood plasma donations. Three of them are located in Daegu and Gyeongsangbuk-do Province. Even if there are applicants, the process is complicated. But medical experts stress now is the best time to develop a blood plasma-based COVID-19 cure. The level of neutralizing antibodies in blood plasma begins to decrease three or four months after infections.

[Soundbite] CHOI WON-SEOK(PROF. KOREA UNIVERSITY ANSAN HOSPITAL) : "The level of antibodies drops naturally. We need more blood donations so that there's enough to conduct three rounds of clinical trials and develop the cure."

Health authorities appropriated an extra budget of 45 billion won to support the development of a COVID-19 treatment. They will also come up with measures to encourage blood plasma donations, such as deploying blood collection buses in hospitals.
kbs가 손수 골랐습니다. 네이버에서도 보세요
News Today 전체보기
기자 정보

    현재 KBS사이트 회원계정의 댓글서비스 로그인 연동기능을 점검중입니다. 불편하시더라도 SNS 계정으로 로그인하신 후 댓글 작성을 부탁드립니다.

    알려드립니다
    KBS 뉴스홈페이지의 스크랩 서비스가 2020년 7월 24일(금) 부로 종료되었습니다.
    사전에 스크랩 내역을 신청하신 이용자께서는 전용 게시판[바로가기▷]에서 확인 가능합니다.
    그동안 스크랩 서비스를 이용해 주셔서 감사드리며, 더 나은 서비스를 제공할 수 있도록 노력하겠습니다. 감사합니다.